Truvestments Capital LLC Buys 9,783 Shares of Semler Scientific Inc. $SMLR

Key Points

• Truvestments Capital LLC significantly increased its stake in Semler Scientific Inc. by 51.3% to a total of 28,865 shares, valued at approximately $1,045,000.
• Semler Scientific reported an impressive earnings per share of $5.04 for the quarter, exceeding analysts' expectations of a loss of ($0.27).
• Analysts have varying outlooks on Semler Scientific, with price targets ranging from $60.00 to $101.00, and a consensus rating of "Buy".

Truvestments Capital LLC grew its stake in shares of Semler Scientific Inc. (NASDAQ:SMLR - Free Report) by 51.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 28,865 shares of the company's stock after buying an additional 9,783 shares during the period. Truvestments Capital LLC owned approximately 0.30% of Semler Scientific worth $1,045,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. BNP Paribas Financial Markets bought a new position in Semler Scientific during the fourth quarter worth about $30,000. Summit Securities Group LLC acquired a new position in shares of Semler Scientific in the 1st quarter valued at approximately $32,000. SBI Securities Co. Ltd. grew its position in shares of Semler Scientific by 161.3% in the 1st quarter. SBI Securities Co. Ltd. now owns 959 shares of the company's stock valued at $35,000 after purchasing an additional 592 shares during the period. NewEdge Advisors LLC grew its position in shares of Semler Scientific by 318.3% in the 4th quarter. NewEdge Advisors LLC now owns 732 shares of the company's stock valued at $40,000 after purchasing an additional 557 shares during the period. Finally, Legal & General Group Plc grew its position in shares of Semler Scientific by 65.4% in the 4th quarter. Legal & General Group Plc now owns 2,056 shares of the company's stock valued at $111,000 after purchasing an additional 813 shares during the period. Institutional investors own 49.37% of the company's stock.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Maxim Group upgraded Semler Scientific to a "strong-buy" rating and set a $95.00 price target on the stock in a report on Wednesday, July 9th. Wall Street Zen lowered Semler Scientific from a "buy" rating to a "sell" rating in a research report on Thursday, May 22nd. Benchmark started coverage on Semler Scientific in a research report on Tuesday, July 8th. They set a "buy" rating and a $101.00 price target on the stock. Finally, Cantor Fitzgerald lowered their price target on Semler Scientific from $61.00 to $60.00 and set an "overweight" rating on the stock in a research report on Wednesday, August 6th. One analyst has rated the stock with a Strong Buy rating and three have given a Buy rating to the company's stock. According to MarketBeat, Semler Scientific currently has a consensus rating of "Buy" and a consensus price target of $81.75.

Semler Scientific Stock Performance

SMLR traded down $0.99 during trading hours on Friday, reaching $29.64. The company's stock had a trading volume of 483,376 shares, compared to its average volume of 577,033. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.58 and a current ratio of 0.60. The company's 50-day moving average is $37.34 and its 200-day moving average is $37.27. Semler Scientific Inc. has a 52 week low of $21.77 and a 52 week high of $81.56. The firm has a market cap of $438.97 million, a PE ratio of 12.20 and a beta of 1.34.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The company reported $5.04 EPS for the quarter, beating analysts' consensus estimates of ($0.27) by $5.31. Semler Scientific had a return on equity of 43.84% and a net margin of 86.20%.The firm had revenue of $8.22 million for the quarter, compared to analyst estimates of $8.10 million.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.